Results from a new phase 1 trial indicate that immunotherapy could be used to treat the most common form of colorectal cancer, also known as bowel cancer. Consistent responses to immunotherapy have been reported in patients with the most common type of colorectal tumors, known as MSS mCRC, with 61% of patients seeing their tumor shrink or remain stable after receiving treatment.
/PRNewswire/ Four out of ten (40%) LGBTQ+ individuals say they re anxious compared to just 3 in 10 (30%) of the population as a whole, according to new.
This webinar will address the current state of the construction market - amid tighter lending standards, and with interest rates finally expected to decline - as we reach the halfway point of 2024. Three top forecasters will share their views on the market prospects for the industry at midyear, both nationally & regionally, in the midst of these unique challenges.
Sponsored by: